117
Participants
Start Date
October 31, 2007
Primary Completion Date
February 28, 2010
Study Completion Date
February 28, 2010
Telaprevir
Tablet
Ribavirin
Tablet
Pegylated interferon alfa 2a
Solution for Injection
Uniklinik Duesseldorf, Düsseldorf
Birmingham
Los Angeles
Kaiser Permanente Internal Medicine, San Diego
San Francisco
University of Colorado Health Sciences Center, Denver
South Denver Gastroenterology, Englewood
University of Florida, Gainesville
Borland-Groover Clinic, Jacksonville
Mayo Clinic Jacksonville, Jacksonville
University of Miami Center for Liver Diseases, Miami
Sarasota
Atlanta Gastroenterology Associates, Atlanta
University of Chicago, Chicago
Indianapolis
Digestive and Liver Disease Clinic, Baton Rouge
Virology Treatment Center, Maine Medical Center, Portland
Johns Hopkins University, Baltimore
Beth Israel Deaconess Medical Center, Boston
University of Massachusetts Memorial Medical Center, Worcester
Henry Ford Hospital, Detroit
St Louis University, St Louis
The Nebraska Medical Center, Omaha
University of New Mexico, Albuquerque
North Shore University Hospital, Manhasset
New York
Duke University Medical Center, Durham
University of Cincinnati, Cincinnati
Cleveland
Penn State Hershey Medical Center, Hershey
University of Pittsburgh Medical Center, Pittsburgh
Columbia Gastroenterology Associates, PA, Columbia
Memphis Gastroenterology Group, Germantown
Liver Institute at Methodist Dallas, Dallas
Houston
Alamo Medical Research, San Antonio
Annandale
University of Virginia Health Systems, Charlottesville
Metropolitan Research, Fairfax
McGuire DVAMC, Richmond
Vienna
University of Calgary Medical Clinic, Calgary
University of Alberta, Edmonton
University of British Columbia Vancouver General Hospital, Vancouver
Winnipeg
Toronto
Hospital Henri Mondor, Créteil
Lyon
Nice
Paris
Pessac
Vandœuvre-lès-Nancy
Berlin
Universitatsklinikum Bonn, Bonn
University of Cologne, Cologne
Frankfurt
Hanover
Academic Medical Center, Amsterdam
Leiden University Medical Center, Leiden
Erasmus MC Medical Center, Rotterdam
Fundacion de Investigation de Diego, Santurce
London
Tibotec, Inc
INDUSTRY
Vertex Pharmaceuticals Incorporated
INDUSTRY